About this Research Topic
Targeted therapies use specific therapeutic agents that specifically target a molecule that is involved in disease progression. By targeting these specific molecules, the molecular pathway of the disease development could be modulated thus inhibiting the disease progression. By specifically targeting a molecule involved in disease development, we can overcome potential side effects, increasing the precision of the treatment.
Precision medicine approaches have been particularly successful in the field of oncology, where targeted therapies have been tested and developed for specific mutations or molecules that promote tumor growth.
This Research Topic is centered around the use of therapeutic agents which specifically target molecules involved in disease progression, the novel therapeutic approaches which are focused on specific molecular pathways that are responsible for disease development, resistance to therapy, and the use of cutting-edge techniques that may put well-known therapies and novel therapies under the same spotlight of precision medicine.
We aim to create a collection of research papers that lead to a better understanding of how oncological and hematological diseases develop and to improve disease management.
We are interested in original research papers, reviews, and also short communications, focused on targeted therapies used in the fields of hematology and, oncology, using state-of-the-art methods to evaluate the response to therapies. We would be grateful to receive both in vitro/in vivo studies, and clinical studies focused on drug repositioning, novel immunotherapies in cancer management, or studies that bring new perspectives to oncological patient management.
Method applications:
- DNA content analysis
- Cell subpopulation analysis by Flow Cytometry
- Minimal residual disease detection
- Diagnosis of immunodeficiency disorders
- Immunophenotyping
- Disease classification and Clinical management
- RNA sequencing
- Single-cell transcriptomics
But not limited to the above-mentioned topics.
Precision medicine approaches have been particularly successful in the field of oncology, where targeted therapies have been tested and developed for specific mutations or molecules that promote tumor growth.
This Research Topic is centered around the use of therapeutic agents which specifically target molecules involved in disease progression, the novel therapeutic approaches which are focused on specific molecular pathways that are responsible for disease development, resistance to therapy, and the use of cutting-edge techniques that may put well-known therapies and novel therapies under the same spotlight of precision medicine.
We aim to create a collection of research papers that lead to a better understanding of how oncological and hematological diseases develop and to improve disease management.
We are interested in original research papers, reviews, and also short communications, focused on targeted therapies used in the fields of hematology and, oncology, using state-of-the-art methods to evaluate the response to therapies. We would be grateful to receive both in vitro/in vivo studies, and clinical studies focused on drug repositioning, novel immunotherapies in cancer management, or studies that bring new perspectives to oncological patient management.
Method applications:
- DNA content analysis
- Cell subpopulation analysis by Flow Cytometry
- Minimal residual disease detection
- Diagnosis of immunodeficiency disorders
- Immunophenotyping
- Disease classification and Clinical management
- RNA sequencing
- Single-cell transcriptomics
But not limited to the above-mentioned topics.
Keywords: Targeted Therapy, Disease Management Pathways, Cell death, Immunotherapy
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
